(SGRY) Surgery Partners, Inc. Porters Five Forces Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(SGRY) Surgery Partners, Inc. Complete Analysis Pack
A Must-Have Tool for Decision-Makers
This Surgery Partners, Inc. Porter's Five Forces Analysis helps you understand the competitive pressures shaping the company’s industry, including rivalry, supplier power, buyer power, substitutes, and new entrants. This page already shows a real sample of the report, and the full purchase gives you the complete ready-to-use analysis instantly.
Suppliers Bargaining Power
Specialized medical devices
Suppliers of implants and advanced surgical devices hold real leverage at Surgery Partners because these products are specialty-specific and quality-critical; a single implant can cost about $1,000-$10,000+, so even small price moves hit margins fast. With products that must be clinically approved across many specialties, switching vendors is hard, and bundle pricing can lock in higher input costs.
Pharma and anesthesia inputs
Drug, anesthesia, and sterile supply vendors hold real power here because outpatient surgery needs steady, compliant input flow. U.S. health systems had more than 300 active drug shortages in 2025, and that can lift закуп costs and disrupt case schedules. Surgery Partners, Inc. has scale, but critical inputs still leave vendors with leverage.
Labor and staffing dependence
Clinical labor suppliers hold high power because nurses, anesthesiologists, and surgical technicians are scarce in many markets. The U.S. Bureau of Labor Statistics projects 6% growth for registered nurses from 2023 to 2033, and that tight labor pool supports premium pay. For Surgery Partners, Inc., higher recruiting and retention costs can lift expenses and cap procedure volume.
Facility and equipment vendors
Facility and equipment vendors have moderate-to-high bargaining power because Surgery Partners, Inc. depends on them for MRI/OR gear, IT, and maintenance that must stay accredited and current. With more than 200 facilities to support, even small price hikes in service, replacement, or software upgrades can lift operating costs fast.
The supplier base is limited for certified medical and IT systems, so switching is slow and costly. That recurring need keeps vendors in a strong spot, especially when compliance, uptime, and patient throughput depend on them.
- Limited qualified vendors
- Higher upkeep and upgrade costs
- Accreditation drives repeat buying
- Switching risk stays high
Managed care contracting leverage
Managed care contracting gives Surgery Partners, Inc. less direct supplier risk than payer risk, but vendors tied to claims, billing, and data systems can still shape reimbursement economics if they sit inside operations. When revenue-cycle tools are embedded, switching costs rise, and that can lift supplier leverage on pricing and contract terms. This makes vendor lock-in and service-level clauses a real margin issue, not just an IT one.
- Embedded vendors can raise switching costs.
- Contract terms affect margin and cash flow.
- Revenue-cycle tools deserve tight oversight.
Suppliers Pressure Surgery Partners’ Costs and Schedules
Suppliers hold moderate-to-high power at Surgery Partners, Inc. because implants, anesthesia, sterile supplies, and clinical labor are specialized and hard to swap. A single implant can cost about $1,000-$10,000+, and U.S. drug shortages topped 300 active cases in 2025, which can raise costs and disrupt schedules.
With more than 200 facilities, Surgery Partners, Inc. still faces vendor leverage in equipment, software, and maintenance. Labor stays tight too, as registered nurses are projected to grow 6% from 2023 to 2033, supporting higher pay.
| Supplier area | Power | Key pressure |
|---|---|---|
| Implants | High | $1,000-$10,000+ each |
| Drugs | High | 300+ shortages in 2025 |
| Clinical labor | High | RN growth 6% |
What is included in the product
Detailed Word Document
Assesses Surgery Partners, Inc.’s competitive pressures from rivals, suppliers, buyers, substitutes, and new entrants.
Customizable Excel Spreadsheet
Quickly see Surgery Partners’ competitive pressures in one clean view—saving time and clarifying strategy.
Reference Sources
Provides a credible source trail for Surgery Partners, Inc., helping users verify assumptions fast and make better decisions.
Customers Bargaining Power
Payer concentration
Commercial insurers, Medicare, and other third-party payers drive most Surgery Partners procedures, and Medicare covered about 66 million people in 2025. Large payers can pressure rates because they control access and reimbursement rules, so they have strong leverage over Surgery Partners. That keeps pricing power modest and makes payer mix a key risk.
Patient price sensitivity
Patients are highly price sensitive because out-of-pocket exposure can be big: KFF said the average family deductible in employer plans was $3,653 in 2024. If Surgery Partners’ prices are unclear, patients may delay or skip outpatient care, especially when they must compare copays and deductibles before booking. That limits Surgery Partners’ ability to raise prices freely.
Employer and physician referrals
Employers and referring physicians steer elective cases, so Surgery Partners, Inc. has less pricing power when they push patients toward lower-cost or better-network sites. Ambulatory surgery centers can cost 45% to 60% less than hospital outpatient departments, which keeps pressure on Surgery Partners, Inc. to compete on access, quality, and convenience. That makes customer bargaining power meaningfully higher in the elective mix.
Switching among outpatient sites
For non-emergency care, patients and payers can move between ambulatory surgery centers and hospital outpatient departments, so Surgery Partners faces real price pressure. Medicare’s site-neutral gap is wide: outpatient surgery at ASCs often costs 30% to 60% less than HOPDs, which gives buyers a strong reason to switch when coverage and physician privileges line up. That keeps rates and service levels under pressure.
- Easy site switching boosts buyer power.
- ASCs often beat HOPDs on price.
- Payers can push for lower rates.
- Access and physician rights still matter.
Outcome and service expectations
Customers have strong leverage because they expect top clinical outcomes, low infection rates, fast scheduling, and quick recovery. If Surgery Partners misses these marks, patients and payers can move cases to other outpatient sites, so service quality directly affects volume.
- Higher outcomes expectations raise switching risk.
- Fast access and low complications drive choice.
- Payers can redirect volume quickly.
Why Surgery Partners Faces Strong Customer Pricing Pressure
Customer bargaining power is high for Surgery Partners, Inc. because most cases depend on commercial payers, Medicare, and employer plans that can steer volume and press rates. Medicare covered about 66 million people in 2025, and KFF said the average family deductible in employer plans was $3,653 in 2024, so patients stay price sensitive. ASCs also face strong site choice pressure, since they often cost 30% to 60% less than hospital outpatient departments.
| Driver | 2025/2024 data | Effect |
|---|---|---|
| Medicare reach | 66 million covered | Strong payer leverage |
| Family deductible | $3,653 | Higher patient price sensitivity |
| ASC vs HOPD cost | 30% to 60% lower | Switching pressure on rates |
Preview the Actual Deliverable
Surgery Partners, Inc. Porter's Five Forces Analysis
You’re previewing the final Surgery Partners, Inc. Porter’s Five Forces analysis—the exact document you’ll receive after purchase. There are no mockups, placeholders, or hidden sections; what you see is what you download. It’s fully formatted, professionally written, and ready for immediate use the moment your payment is complete.
Rivalry Among Competitors
Many local facility competitors
Surgery Partners faces tight local rivalry from other ambulatory surgery centers, specialty physician groups, and hospital outpatient departments. With more than 6,000 U.S. ambulatory surgery centers, nearby patients and referring doctors often choose the closest, best-networked site. In dense metro markets, that local choice pressure can push prices, case mix, and physician loyalty.
Pressure from hospitals
Hospitals are a strong competitive threat to Surgery Partners, Inc. because they can keep outpatient procedures in-house and steer patients across wider service lines. They can also bundle care or absorb lower pricing, which puts pressure on Surgery Partners, Inc.’s rates and margins. That makes it harder to win share, especially in markets where hospitals control referrals and operating rooms.
Specialty-based competition
Surgery Partners, Inc. faces specialty-based rivalry across orthopedics, GI, ophthalmology, pain management, and other service lines, where each market has its own local leaders. In these niches, physician alignment and center reputation drive volume, so rivals with stronger doctor ties can shift cases fast. That makes competition less about price alone and more about access, trust, and procedure flow.
Capacity and utilization battles
Capacity and utilization are the main battlegrounds for Surgery Partners, Inc. and peers: higher room fill and a better procedure mix spread fixed costs across more cases, so even small shifts in throughput can swing margins. That is why rivals push hard for surgeon volume, referral share, and new site builds, often leading to pricing pressure and local expansion races.
- Higher utilization lifts margin
- Surgeons drive case volume
- Referral capture is contested
- Expansion can trigger pricing cuts
Quality and efficiency differentiation
Quality and efficiency drive rivalry in Surgery Partners, Inc.’s markets because payers and patients compare price, wait time, and outcomes. Surgery Partners reported $3.1 billion in net revenue in 2024, so even small gains in lower-cost care, faster scheduling, and better patient experience can move share. Operators that deliver shorter waits and strong outcomes can win referrals and repeat volume.
- Lower-cost care wins contracts.
- Shorter waits improve demand.
- Quality gaps raise competitive pressure.
Still, rivalry stays high because peers must keep investing in staff, technology, and quality metrics just to hold position.
High Rivalry Pressures Surgery Partners’ Growth
Competitive rivalry for Surgery Partners, Inc. stays high because local ambulatory surgery centers, hospitals, and specialty groups fight for the same surgeons, referrals, and cases. More than 6,000 U.S. ambulatory surgery centers keep price and access pressure intense. Surgery Partners, Inc. reported $3.1 billion in 2024 net revenue, so small share shifts can move results.
| Metric | Implication |
|---|---|
| 6,000+ ASCs | Dense local rivalry |
| $3.1B net revenue | Share gains matter |
Substitutes Threaten
Hospital outpatient departments
Hospital outpatient departments are Surgery Partners, Inc.'s most direct substitute for many procedures, especially higher-acuity cases and physician groups tied to hospitals. Medicare's 2025 outpatient prospective payment system keeps that channel highly relevant, so patients and doctors can still shift volume there when needed. That pressure caps Surgery Partners, Inc.'s pricing power and slows share gains.
Inpatient surgery alternatives
Inpatient surgery still competes with ambulatory centers because some procedures need overnight care, and higher-risk patients are often safer in hospitals. CMS has kept expanding the outpatient pathway, but hospitals still anchor complex cases, so Surgery Partners must prove lower total cost and faster recovery on every case. The pressure is real: if a case can be done safely in both settings, price and convenience decide the winner.
Non-surgical treatment paths
Medication, physical therapy, injections, and lifestyle changes can delay or replace some procedures, especially in orthopedics and pain management, where many cases start with non-surgical care. As these options improve, Surgery Partners, Inc. can face lower procedure volumes and slower case conversion. That makes the threat of substitutes meaningfully high.
Telehealth and remote management
Telehealth doesn’t replace Surgery Partners, Inc. procedures, but it can move diagnosis, triage, and follow-up away from the center. CMS kept many telehealth flexibilities through September 30, 2025, so remote care still supports conservative treatment first and can slow conversion to surgery. That weakens volume at the margin, especially for cases that depend on in-person escalation.
- Shifts care before surgery
- Reduces in-person visits
- Delays surgical conversion
Emerging lower-acuity care settings
Emerging lower-acuity sites are a real substitute for Surgery Partners, Inc. as more procedures move to office-based and freestanding settings; CMS expanded the ASC Covered Procedures List to 2,037 procedures for 2025, widening the pool that can shift away from surgery centers.
As devices and anesthesia improve, simpler, less invasive cases can bypass higher-cost facilities, which can pressure Surgery Partners, Inc. case volume and pricing. The risk is highest in orthopedics, pain, and GI, where payers keep steering care to cheaper sites.
- More procedures qualify for lower-cost sites
- Volume can shift away from Surgery Partners, Inc.
- Simple, low-risk cases face the most pressure
Substitutes Threaten Surgery Partners’ Volume and Pricing
Threat of substitutes is high for Surgery Partners, Inc. because hospitals, inpatient surgery, drug therapy, rehab, and telehealth can all pull cases away. CMS raised the ASC Covered Procedures List to 2,037 for 2025, but that also shows how many procedures can still shift to cheaper sites.
| Substitute | 2025 signal | Impact |
|---|---|---|
| Hospitals | Medicare OPPS active | Pricing pressure |
| Telehealth | Flexibilities through Sep. 30, 2025 | Slower conversion |
| Lower-cost sites | 2,037 ASC procedures | Volume risk |
Entrants Threaten
Capital and licensing barriers
Building an accredited surgical facility can take tens of millions of dollars, plus state licenses, Medicare certification, and clinical compliance, so the entry bar is high. For Surgery Partners, Inc., that cuts down new rivals in most markets. Still, well-funded health systems and private equity-backed groups can enter select local markets where demand and payer mix are strong.
Physician alignment requirements
Physician alignment is a real moat for Surgery Partners, Inc.: new entrants must win surgeons and specialists who already send cases to established centers. In a market with roughly 6,000+ U.S. ambulatory surgery centers, referral ties are sticky, so recruitment is hard and costly. Without aligned physicians, a new site struggles to fill blocks, scale volume, and earn payback.
Payer contracting hurdles
Payer contracting is a real barrier for new entrants because Surgery Partners, Inc. needs insurer and employer network deals before volume becomes reimbursable. New centers often spend months, sometimes longer, getting favorable status, while Surgery Partners already has long ties across a large multi-state platform, which helps defend patient flow and pricing.
Operational expertise needs
Surgery center ops need deep skill in staffing, sterilization, scheduling, compliance, and revenue cycle work. Surgery Partners operated about 180 facilities across 33 states and logged about $3.1 billion in 2024 revenue, showing how scale and repeat know-how matter. New entrants often miss the cost and process load behind efficient throughput.
- Complex ops raise startup risk.
- Scale helps spread fixed costs.
- Experience cuts errors and delays.
Local market access constraints
Local market access is tight for Surgery Partners, Inc.; prime sites, physician deals, and referral paths are often already locked up, so new rivals face slower, pricier entry. In many U.S. markets, that favors incumbents and protects case flow. Still, niche entrants can break in where specialty demand is thin or fast-growing.
- Occupied locations raise entry costs
- Physician ties are hard to displace
- Underserved niches still attract entrants
Surgery Partners’ moat: high startup costs and hard-to-win contracts
Threat of new entrants for Surgery Partners, Inc. stays low because new centers face heavy capital needs, licensing, Medicare certification, payer contracts, and surgeon alignment. With about 180 facilities in 33 states and about $3.1 billion in 2024 revenue, Surgery Partners, Inc. shows the scale and operating depth that new rivals must match.
| Barrier | Why it matters |
|---|---|
| Capital and licenses | High startup cost |
| Physician ties | Hard to win referrals |
| Payer contracts | Slow reimbursement access |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.